Relationship between changes in prostate-specific antigen and prognosis of prostate cancer
Authors:
- Jay D. PearsonJPJay D. Pearson
- Alan W. PartinAPAlan W. Partin
- Jonathan I. EpsteinJEJonathan I. Epstein
- H.BAllentine CarterHCH.BAllentine Carter
Open Access
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volumeCancer, 1993
- Cell Proliferation in Prostatic Adenocarcinoma: In Vitro Measurement by 5-Bromodeoxyuridine Incorporation and Proliferating Cell Nuclear Antigen ExpressionJournal of Urology, 1993
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, 1990
- Symptoms and signs of prostatism as risk factors for prostatectomyThe Prostate, 1990
- The prostate: An increasing medical problemThe Prostate, 1990
- Nuclear Roundness Factor Measurement for Assessment of Prognosis of Patients with Prostatic Carcinoma. II. Standardization of Methodology for Histologic SectionsJournal of Urology, 1988
- Nuclear Roundness Factor Measurement for Assessment of Prognosis of Patients With Prostatic Carcinoma. I. Testing Of A Digitization SystemJournal of Urology, 1988
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- A New Method to Assess Metastatic Potential of Human Prostate Cancer: Relative Nuclear RoundnessJournal of Urology, 1982